|
ホンダ ゴロウ
HONDA Gorou
本田 五郎 所属 医学部 医学科(東京女子医科大学病院) 職種 教授・基幹分野長 |
|
| 論文種別 | 総説 |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Diagnostic Method Advancement to Improve the Prognosis of Pancreatic Ductal Adenocarcinoma |
| 掲載誌名 | 正式名:Diagnostics 略 称:Diagnostics (Basel) ISSNコード:20754418/20754418 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 16(14),pp.2286 |
| 著者・共著者 | Pradez Sapkota,KIKUYAMA Masataka,HONDA Goro |
| 担当区分 | 最終著者 |
| 発行年月 | 2026/07 |
| 概要 | Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, and early diagnosis is essential for improving patient outcomes. Conventional imaging modalities such as ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) have limitations in detecting small PDAC. Endoscopic ultrasonography (EUS) is useful for identifying small lesions; however, even small PDAC can be invasive and may metastasize, resulting in Stage IV disease. The most effective way to improve the prognosis of PDAC is to diagnose lesions confined to the ductal epithelium, such as high-grade pancreatic intraepithelial neoplasia (HG-PanIN) or carcinoma in situ (CIS). Identifying focal pancreatic parenchymal atrophy (FPPA) on CT or MRI may suggest the presence of HG-PanIN/CIS and prompt further evaluation using serial pancreatic juice aspiration cytologic examination (SPACE). Recognizing FPPA and performing SPACE enables the diagnosis of PDAC at Stage 0 (HG-PanIN/CIS), which can lead to improved prognosis. |
| DOI | 10.3390/diagnostics16142286 |
| PMID | 42510149 |